¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"amino acid composition"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • benzoic acid
    º¥Á¶»ê
  • bile acid
    ´ãÁó»ê
  • boric acid
    ºØ»ê
  • boric acid ointment
    ºØ»ê¿¬°í
  • boric acid poisoning
    ºØ»êÁßµ¶
  • butyric acid
    ºÎƼ¸£»ê
  • cacodylic acid
    Ä«ÄÚµô»ê
  • citric acid
    ½ÃÆ®¸£»ê, ±¸¿¬»ê
  • citric acid cycle
    ½ÃÆ®¸£»êȸ·Î, ±¸¿¬»êȸ·Î
  • carbamic acid
    Ä«¸£¹Ù¹Î»ê
  • carbolic acid
    ¼®Åº»ê
  • carbolic acid gangrene
    ¼®Åº»ê±«Àú
  • conjugated acid
    ¦»ê, °áÇÕ»ê
  • carbonic acid
    ź»ê
  • caffeic acid
    Ä«ÆäÀλê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • caffeic acid
    Ä«ÆäÀλê
  • carbolic acid
    (¢¡phenol) Æä³î, ¼®Åº»ê
  • carbonic acid
    ź»ê
  • chamber acid
    ¿¬½ÇȲ»ê
  • chitonic acid
    Űſ»ê
  • cholic acid
    ´ãÁó»ê
  • citric acid
    ±¸¿¬»ê, ½ÃÆ®¸£»ê
  • conjugated acid
    ¦»ê, °ø¾×»ê, °áÇÕ»ê
  • corrosive acid
    ºÎ½Ä»ê
  • cyanuric acid
    ½Ã¾Æ´©¸£»ê
  • cyclopaldic acid
    ½ÃŬ·ÎÆÈµå»ê
  • deoxycholic acid
    µð¿Á½ÃÄݸ°»ê
  • deoxyribonucleic acid
    µð¿Á½Ã¸®º¸ÇÙ»ê, µð¿£¿¡ÀÌ
  • desoxyribonucleic acid
    (¢¡deoxyribonucleic acid) µð¿Á½Ã¸®º¸ÇÙ»ê, µð¿£¿¡ÀÌ
  • dibasic acid
    ÀÌ¿°±â»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Lactic acid = lactate
    ¶ôÆ®»ê(¡­ß«),Á¥»ê(¡­ß«)
  • Lactic acid dehydrogenase
    ¶ôÆ® »êÅ»¼ö¼ÒÈ¿¼Ò(¡­ß«÷­â©áÈý£áÈ)
  • N-Benzol-L-tyrosyl-p-aminobenzoic acid
    N-º¥Á¹-L-Ƽ·Î½Ç-p- ¾Æ¹Ì³ë¾È½ÄÇâ»ê
  • N-Formiminoglutamic acid
    N-Æ÷¸§À̹̳ë±Û·çŽ»ê
  • RNA =>ribonucleic acid
    ¸®º¸ÇÙ»ê
  • RNA=£¾ribonucleic acid
    ¸®º¸ÇÙ»ê.
  • VMA =>vanillymandelic acid
    ¹Ù´Ò¸¸µ¥¸¯»ê
  • abietolic acid
    ¾Æºñ¿¡Åç»ê.
  • acetic acid
    ¾Æ¼¼Æ®»ê, ÃÊ»ê(õ³ß«).
  • acetic acid
    ¾Æ¼¼Æ®»ê
  • acetoacetic acid
    ¾Æ¼¼Å侯¼¼Æ®»ê.
  • acetoacetic acid
    ¾Æ¼¼Å侯¼¼Æ®»ê
  • acetylsalicylic acid
    ¾Æ¼¼Æ¿»ì¸®½Ç»ê
  • acid phosphatase
    »êÀλêÈ¿¼Ò
  • acid alcohol
    »ê¼º¾ËÄÚ¿Ã.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • acetoacetic acid
    ¾Æ¼¼Å侯¼¼Æ®»ê.
  • acetylsalicylic acid
    ¾Æ¼¼Æ¿»ì¸®½Ç»ê
  • acid phosphatase
    »êÀλêÈ¿¼Ò
  • acid alcohol
    »ê¼º¾ËÄÚ¿Ã.
  • acid ash diet
    »ê¼º½ÄÀÌ.
  • acid aspiration syndrome
    À§»ê ÈíÀÔ ÁõÈıº
  • acid bath
    »ê¿å(ß«é±).
  • acid burn
    »ê¼ºÈ­»ó
  • acid burn
    »ê¼º¿Ü»ó, »ê¼ºÈ­»ó.
  • acid catalyser
    »êÃ˸Å(ß«õºØÚ).
  • acid challenge test
    »ê Åõ¿©½ÃÇè
  • acid citrate dextrose
    »ê ±¸¿¬»ê¿°Æ÷µµ´ç
  • acid dyspepsia
    ´Ù»ê¼º(Òýß«àõ) ¼ÒÈ­ºÒ·®(Áõ).
  • acid elution slide test
    »ê¿ëÃâ½½¶óÀ̵å½ÃÇè
  • acid error
    »ê¿ÀÂ÷(ß«è¦ó¬).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • mixed amino acid fermentation
    È¥ÇÕ(ûèùê)¾Æ¹Ì³ë»ê¹ßÈ¿(Û£ý£)
  • neutral amino acid
    Áß¼º(ñéàõ) ¾Æ¹Ì³ë»ê(ß«)
  • nonpolar amino acid
    ¹«±Ø¼º(Ùíпàõ) ¾Æ¹Ì³ë»ê(ß«)
  • nonprotein amino acid
    ºñ´Ü¹éÁú(ÞªÓ±ÛÜòõ) ¾Æ¹Ì³ë»ê(ß«)
  • phenylthiocarbamyl amino acid
    Æä´ÒƼ¿ÀÄ«¸£¹Ù¹Ð¾Æ¹Ì³ë»ê(ß«)
  • phenylthiohydantoin amino acid
    Æä´ÒƼ¿ÀÇÏÀÌ´ÜÅäÀξƹ̳ë»ê(ß«)
  • polar amino acid
    ±Ø¼º(пàõ) ¾Æ¹Ì³ë»ê(ß«)
  • primary amino acid
    ÀÏÂ÷(ìéó­) ¾Æ¹Ì³ë»ê(ß«)
  • PTC-amino acid
    PTC ¾Æ¹Ì³ë»ê(ß«)
  • PTH-amino acid
    PTH ¾Æ¹Ì³ë»ê(ß«)
  • radical amino acid replacement
    ¶óµðÄ® ¾Æ¹Ì³ë»ê ġȯ(öÇüµ)
  • rare amino acid
    Èñ±Í(ýüÏþ) ¾Æ¹Ì³ë»ê
  • sulfur amino acid
    Ȳ(üÜ)¾Æ¹Ì³ë»ê(ß«)
  • uncharged polar amino acid
    ¹«ÀüÇÏ(Ùíï³ùÃ) ±Ø¼º(пàõ)¾Æ¹Ì³ë»ê(ß«)
  • uncoded amino acid
    ¹«(Ùí)ÄÚµ· ¾Æ¹Ì³ë»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
BCAA Branched Chain Amino Acid
¥â-ABA ¥â-Amino-Butyric Acid
Bz-Ty-PABA test N-Benzoyl-L-Tyrosyl-p-Amino-Benzoic Acid test
  = Bentiromide test
  = Tr...
¥ä-ALA ¥ä-Amino-Levulinic Acid
¥ä-ALAD ¥ä-Amino-Levulinic Acid Dehydratase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
GABA 4-Amino-n-butyric acid
5-ASA 5 amino salicylic acid
6-APA 6-Amino penicillanic acid
7-ACA 7-amino cephalosporanic acid
AOAA Amino-oxyacetic acid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acid-gel application
    °ÖÇü »ê Àû¿ë
  • adenylic acid deaminase
    ¾Æµ¥´Ò»ê Å»¾Æ¹Ì³ë È¿¼Ò
  • aldobionic acid
    ¾Ëµµºñ¿Â»ê
    C11H19O10COOH. ±× ¼ººÐ´çÀÇ Çϳª·Î¼­ ¿ì·Ð»êÀ» ÇÔÀ¯Çϰí ÀÖ´Â ÀÌ´ç·ùÀ̸ç, ¿©·¯ Á¾·ùÀÇ ½Ä¹°¼º °í¹«¿Í ƯÁ¤ÇÑ º´¿øÃ¼ Áß¿¡ Á¸ÀçÇÑ´Ù. Æó·Å±Õ 3ÇüÀÇ Æ¯¼ö ´Ù´ç·ùÀÇ °¡¼öºÐÇØ¿¡ ÀÇÇØ¼­ ¾òÀ» ¼ö ÀÖ´Ù.
  • allokainic acid
    ¾Ë·ÎÄ«ÀÎ »ê
  • alloxyproteic acid
    ¾Ë·Ï½Ã ´Ü¹é»ê
    ¶§¶§·Î ´¢ Áß¿¡ ¹è¼³µÇ´Â À¯È² ÇÔÀ¯ È­ÇÕ¹°.
  • alpha-oxynaphthoic acid
    ¾ËÆÄ-¿Á½Ã³ªÇÁÅä»ê
    °áÁ¤¼ºÀÇ »ê,OHC10H6COOH.°ú°Å¿¡´Â ¹æºÎÁ¦, ¹æÃëÁ¦·Î »ç¿ëµÇ¾ú´Ù.
  • aminoacetic acid
    ¾Æ¹Ì³ë¾Æ¼¼Æ®»ê, ¾Æ¹Ì³ëÃÊ»ê
    ºñÇʼö ¾Æ¹Ì³ë»ê, NH2CH2COOH. ¸¹Àº ´Ü¹éÁúÀÇ ±¸¼º ¼ººÐÀ¸·Î Á¸ÀçÇÑ´Ù. ÇÕ¼ºµÇ°í ÀÖÀ¸¸ç À§ Á¦»êÁ¦¿Í º¸Ãæ½ÄǰÀ¸·Î »ç¿ëµÇ¾îÁø´Ù. ¶ÇÇÑ ¿©·¯ °¡Áö ±ÙÀ°º´ ¹× ¸»ÃÊÇ÷°ü ºÎÀüÁõÀÇ Ä¡·á¿¡µµ »ç¿ëµÈ´Ù.
  • aminobenzoic acid
    ¾Æ¹Ì³ë ¾È½ÄÇâ »ê
    C7H7NO2. ½Ä¹°°ú µ¿¹°Á¶Á÷¿¡ ³Î¸® ºÐÆ÷Çϸç, ºñŸ¹Î B±ºÀÇ ±¸¼º ¼ººÐ¿¡ °ü°èµÈ´Ù. ¼³ÆÄÁ¦ÀÇ Á¤±ÕÀÛ¿ëÀ» ¹«È¿È­½ÃŲ´Ù.
  • arachidonic acid
    ¾Æ¶ó۵·»ê
    1. °íµµÀÇ ºÒÆ÷È­ Çʼö Áö¹æ»ê. CH3
  • arachidonic acid metabolism
    ¾Æ¶ó۵·»ê ´ë»ç¹°Áú
  • arsenic acid
    ºñ»ê
    HAsO©þ. À̰ÍÀÇ ¿°À» ºñ»ê¿°À̶ó°í ºÎ¸£¸ç ÀǾàǰÀ¸·Î ¾²ÀδÙ.
  • arsenoacetic acid
    ¾Æ¸£¼¼³ë¾Æ¼¼Æ®»ê
  • ascorbic acid deficiency
    ¾Æ½ºÄÚ¸£ºó»ê °áÇÌÁõ
    Ư¡ÀûÀÎ ±«Ç÷º´ÀÌ ³ªÅ¸³ª¸ç ÀÌÀÇ Áõ»óÀ¸·Î´Â ÀÕ¸öÀÌ º×°í ½±°Ô ÃâÇ÷ÀÌ µÇ°í, Ä¡¾Æ Çü¼º Àå¾Ö Ä¡Á¶°ñ Èí¼ö ÇÇÇÏ ÃâÇ÷ µîÀÌ ÀÖÀ¸¸ç â»ó Ä¡À¯°¡ ´Ê¾îÁø´Ù.
  • available phosphoric acid
    À¯È¿ Àλê
  • basal acid output
    ±âÀú»ê ¹èÃâ·®
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
excitatory amino acid <biochemistry> The naturally occurring amino acids L glutamate and L aspartate and their synthetic analogues, notably kainate, quisqualate and NMDA. They have the properties of excitatory neurotransmitters in the CNS, may be involved in long-term potentiation and can act as excitotoxins.
at least three classes of EAA receptor have been identified, the agonists of the N type receptor are L aspartate, NMDA and ibotenate, the agonists of the Q type receptor are L glutamate and quisqualate, agonists of the K type are L glutamate and kainate. All three receptor types are found widely in the CNS and particularly the telencephalon, N and Q type receptors tend to occur together and may interact, their distribution is complementary to the K type receptors. The ion fluxes through the Q and K receptors are relatively brief, whereas the flux through the N type is longer and carries a significant amount of calcium. Additionally the N type receptor is blockaded by magnesium near the resting potential and thus shows voltage gated ion channel properties, leading to a regenerative response, this is why N type receptors have been linked to long-term potentiation.
Invertebrate glutamate receptors may not have the same properties as those described above.
(18 Nov 1997)
excitatory amino acid agents Drugs used for their actions on any aspect of excitatory amino acid neurotransmitter systems. Included are drugs that act on excitatory amino acid receptors, affect the life cycle of excitatory amino acid transmitters, or affect the survival of neurons using excitatory amino acids.
(12 Dec 1998)
excitatory amino acid agonists Drugs that bind to and activate excitatory amino acid receptors.
(12 Dec 1998)
excitatory amino acid antagonists Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists.
(12 Dec 1998)
1-carbamoyl-L-amino acid amidohydrolase <enzyme> From bacillus stearothermophilus; amino acid sequence given in first source
Registry number: EC 3.5.1.-
Synonym: carbamoyl l-aa amidohydrolase, n-carbamyl-l-amino acid amidohydrolase
(26 Jun 1999)
amino- <prefix> Prefix denoting a compound containing the radical, -NH2.
Origin: an(monia) + in(e) + -o-
(05 Mar 2000)
amino acids Organic compounds that generally contain an amino (-nh2) and a carboxyl (-cooh) group. Twenty alpha-amino acids are the subunits which are polymerised to form proteins.
(12 Dec 1998)
amino acids, branched-chain Amino acids which have a branched carbon chain.
(12 Dec 1998)
amino acids, cyclic A class of amino acids characterised by a closed ring structure.
(12 Dec 1998)
amino acids, peptides, and proteins Amino acids and chains of amino acids connected by peptide linkages.
(12 Dec 1998)
amino acyl-tRNA ligases <enzyme> Any of the group of ligases that catalyses the ATP-driven formation of a bond between an amino acid and a trna, activating the amino acids as a step in protein synthesis. Individual enzymes are highly specific for one amino acid and for any trna corresponding to that amino acid.
Registry number: EC 6.1.1.
(12 Dec 1998)
amino alcohols Compounds possessing both a hydroxyl (-oh) and an amino group (-nh2).
(12 Dec 1998)
amino group <biochemistry> An -NH2 group. Organic compounds which have this group are called amines.
(09 Oct 1997)
amino sugar <biochemistry> Monosaccharide in which an OH group is replaced with an amino group, often acetylated. Common examples are D galactosamine, D glucosamine, neuraminic acid, muramic acid. Amino sugars are important constituents of bacterial cell walls, some antibiotics, blood group substances, milk oligosaccharides and chitin.
(18 Nov 1997)
amino sugars Sugar's in which a hydroxyl group has been replaced with an amino group; e.g., d-glucosamine.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • inosinic acid
    À̳ë½Å»ê
  • iodic acid
    ¿ä¿Àµå»ê
  • isonicotinic acid hydrazide
    (¾à)À̼ҴÏÄÚÆ¾»ê ÇÏÀ̵å¶óÁöµå(°áÇÙ Ä¡·áÁ¦)
  • lactic acid
    À¯»ê
  • maleci acid
    ¸»·¹»ê
  • malic acid
    (È­) »ç°ú»ê
  • margaric acid
    ¸¶¸£°¡¸£»ê
  • methacrylic acid
    ¸ÞŸũ¸±»ê
  • muriatic acid
    ¿°»ê
  • naildixic acid
    (È­)³¯¸®µñ½Å»ê(ºñ´¢,»ý½Ä±â °¨¿°Áõ Ä¡·á¿ë Ç×»ý¹°Áú)
  • nitric acid
    Áú»ê
  • nitrous acid
    ¾ÆÁú»ê
  • nucleic acid
    (»ýÈ­)ÇÙ»ê
  • oleic acid
    ¿Ã·¹ÀÎ »ê
  • oxalic acid
    ¼ö»ê
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á